Literature DB >> 18474835

Left ventricular filling pressure by Doppler echocardiography in patients with end-stage renal disease.

Angela Y-M Wang1, Mei Wang, Christopher W-K Lam, Iris H-S Chan, Yan Zhang, John E Sanderson.   

Abstract

Left ventricular hypertrophy and systolic dysfunction predict mortality in patients with end-stage renal disease. However, the prognostic value of left ventricular filling pressure has remained uncertain in this population. We evaluated whether the early mitral inflow velocity to peak mitral annulus velocity (E/Em) ratio, an estimate of left ventricular filling pressure by tissue Doppler imaging, has significant additional prognostic value to conventional echocardiographic parameters and other clinical and biochemical parameters in 220 patients with end-stage renal disease. The E/Em ratio was elevated (>15) in 62% of the patients. Multivariate analysis showed that an elevated E/Em ratio had the highest correlation with left ventricular volume index, followed by loss of residual glomerular filtration rate, increasing age, worsening ejection fraction, and diabetes. During the median follow-up of 48 months, the E/Em ratio emerged as an independent predictor of all-cause mortality (adjusted hazard ratio: 1.027; 95% CI: 1.003 to 1.051; P=0.026) and cardiovascular death (adjusted hazard ratio: 1.033; 95% CI: 1.002 to 1.065; P=0.035) in the multivariable Cox regression analysis. In addition, the E/Em ratio added significant incremental prognostic value for all-cause mortality (P=0.035) and cardiovascular death (P=0.035) beyond the standard clinical, biochemical, and dialysis parameters and echocardiographic measurements. In conclusion, the E/Em ratio displayed important additional long-term prognostic information above and beyond that of left ventricular mass and systolic function. Our data suggest that left ventricular filling pressure should be estimated during echocardiographic examination for additional prognostication in patients with end-stage renal disease.

Entities:  

Mesh:

Year:  2008        PMID: 18474835     DOI: 10.1161/HYPERTENSIONAHA.108.112334

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  31 in total

1.  What Is the Meaning of Increased Myocardial Injury Enzymes during Hemodialysis? A Tissue Doppler Imaging Study.

Authors:  Gürsel Yildiz; Mansur Kayataş; Ferhan Candan; Mehmet Birhan Yilmaz; Ali Zorlu; Savaş Sarikaya
Journal:  Cardiorenal Med       Date:  2013-06-25       Impact factor: 2.041

2.  Incremental value of global longitudinal strain in prediction of all-cause mortality in predialysis and dialysis chronic kidney disease patients.

Authors:  Ivana Valocikova; Marianna Vachalcova; Gabriel Valocik; Marian Kurecko; Mariana Dvoroznakova; Peter Mitro; Jozefina Cocherova; Stanislava Buday Bujnakova; Dusan Holoubek
Journal:  Wien Klin Wochenschr       Date:  2016-03-14       Impact factor: 1.704

3.  Relation of N-terminal pro-B-type natriuretic peptide (NT-proBNP) and left atrial volume index to left ventricular function in chronic hemodialysis patients.

Authors:  Mayuko Yamazaki; Tetsuya Ogawa; Noriko Tamei; Yoshitaka Ando; Kosaku Nitta
Journal:  Heart Vessels       Date:  2010-12-03       Impact factor: 2.037

Review 4.  Preoperative Noncoronary Cardiovascular Assessment and Management of Kidney Transplant Candidates.

Authors:  Jayson Rakesh Baman; Joseph Knapper; Zankhana Raval; Matthew E Harinstein; John J Friedewald; Kameswari Maganti; Michael J Cuttica; Michael I Abecassis; Ziad A Ali; Mihai Gheorghiade; James D Flaherty
Journal:  Clin J Am Soc Nephrol       Date:  2019-09-25       Impact factor: 8.237

Review 5.  Echocardiographic assessment of cardiac structure and function in chronic renal disease.

Authors:  Kaoru Dohi
Journal:  J Echocardiogr       Date:  2019-07-08

6.  Safety and cardiovascular efficacy of spironolactone in dialysis-dependent ESRD (SPin-D): a randomized, placebo-controlled, multiple dosage trial.

Authors:  David M Charytan; Jonathan Himmelfarb; T Alp Ikizler; Dominic S Raj; Jesse Y Hsu; J Richard Landis; Amanda H Anderson; Adriana M Hung; Rajnish Mehrotra; Shailendra Sharma; Daniel E Weiner; Mark Williams; Marcelo DiCarli; Hicham Skali; Paul L Kimmel; Alan S Kliger; Laura M Dember
Journal:  Kidney Int       Date:  2018-11-23       Impact factor: 10.612

7.  Predictors of increased left ventricular filling pressure in dialysis patients with preserved left ventricular ejection fraction.

Authors:  Gani Bajraktari; Mimoza Berbatovci-Ukimeraj; Ali Hajdari; Lavdim Ibraimi; Irfan Daullxhiu; Ymer Elezi; Gjin Ndrepepa
Journal:  Croat Med J       Date:  2009-12       Impact factor: 1.351

8.  Prediction of hospital outcome in septic shock: a prospective comparison of tissue Doppler and cardiac biomarkers.

Authors:  David J Sturgess; Thomas H Marwick; Chris Joyce; Carly Jenkins; Mark Jones; Paul Masci; David Stewart; Bala Venkatesh
Journal:  Crit Care       Date:  2010-03-24       Impact factor: 9.097

9.  Predicting cardiovascular disease morbidity and mortality in chronic kidney disease in Spain. The rationale and design of NEFRONA: a prospective, multicenter, observational cohort study.

Authors:  Mireia Junyent; Montserrat Martínez; Mercè Borràs; Blai Coll; Jose Manuel Valdivielso; Teresa Vidal; Felipe Sarró; Jordi Roig; Lourdes Craver; Elvira Fernández
Journal:  BMC Nephrol       Date:  2010-07-07       Impact factor: 2.388

Review 10.  ISPD Cardiovascular and Metabolic Guidelines in Adult Peritoneal Dialysis Patients Part II - Management of Various Cardiovascular Complications.

Authors:  Angela Yee Moon Wang; K Scott Brimble; Gillian Brunier; Stephen G Holt; Vivekanand Jha; David W Johnson; Shin-Wook Kang; Jeroen P Kooman; Mark Lambie; Chris McIntyre; Rajnish Mehrotra; Roberto Pecoits-Filho
Journal:  Perit Dial Int       Date:  2015 Jul-Aug       Impact factor: 1.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.